Intas Pharmaceuticals Ltd.
🇮🇳India
- Country
- 🇮🇳India
- Ownership
- Holding
- Established
- 2000-01-01
- Employees
- 1K
- Market Cap
- -
- Website
- http://www.intaspharma.com
Comparative, Pharmacokinetic and Pharmacodynamic Study of Subcutaneous Injections of INTP5 of Intas Pharmaceuticals Ltd., India Against Neulasta of Amgen Inc., USA in Healthy, Adult Human Subjects.
Phase 1
Completed
- Conditions
- Pharmacokinetic Bioequivalence Study in Human Healthy Volunteers
- Interventions
- Combination Product: INTP5Combination Product: US Neulasta
- First Posted Date
- 2019-07-10
- Last Posted Date
- 2019-10-04
- Lead Sponsor
- Intas Pharmaceuticals, Ltd.
- Target Recruit Count
- 144
- Registration Number
- NCT04014062
- Locations
- 🇮🇳
Lambda Therapeutic Research Ltd., Ahmedabad, Gota, India
Comparative Immunogenicity Study of Multiple Doses of Proposed Pegfilgrastim Biosimilar, INTP5 of Intas Pharmaceuticals Ltd., India Against Neulasta of Amgen Inc., USA in Healthy, Adult Human Subjects.
Phase 1
Completed
- Conditions
- ImmunogenicityHealthy Volunteers
- Interventions
- Combination Product: INTP5Combination Product: US Neulasta
- First Posted Date
- 2019-07-10
- Last Posted Date
- 2019-10-04
- Lead Sponsor
- Intas Pharmaceuticals, Ltd.
- Target Recruit Count
- 200
- Registration Number
- NCT04015232
- Locations
- 🇮🇳
Lambda Therapeutic Research Ltd., Ahmedabad, Gota, India
© Copyright 2025. All Rights Reserved by MedPath